Guenter Hans Benz

This inventor holds 6 USPTO granted patents. Top assignees: Bayer Corporation, Other. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guenter Hans Benz. Retrieved from https://idiyas.com/inventor/guenter-hans-benz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 44(Granted Patents)

Company Filing History:

5 out of 1,013

Bayer Corporation

patents

1 out of 834,570

Other

patents

Years Active: 1998-2000

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6166082 - Substituted 5-biarylpentanoic acids and derivatives as matrix (2000-12-26),

2. 5886024 - Thiophene-containing butonic acid derivatives as matrix metalloprotease (1999-03-23),

3. 5874473 - Substituted cycloalkanecarboxylic acid derivatives as matrix (1999-02-23),

4. 5861427 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-19),

5. 5854277 - Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors (1998-12-29),

6. 5789434 - Derivatives of substituted 4-biarylbutyric acid as matrix (1998-08-04),

Title: Guenter Hans Benz: Innovator in Pharmaceutical Chemistry

Introduction

Guenter Hans Benz is a notable inventor based in Velbert, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of matrix metalloprotease inhibitors. With a total of 6 patents to his name, his work has implications for treating various physiological conditions.

Latest Patents

Benz's latest patents include innovative compounds such as substituted 5-biarylpentanoic acids and thiophene-containing butonic acid derivatives. These compounds serve as matrix metalloprotease inhibitors and are designed for use in pharmaceutical compositions. The generalized formulas of these compounds highlight their potential in treating a variety of physiological conditions.

Career Highlights

Throughout his career, Guenter Hans Benz has worked with prominent organizations, including Bayer Corporation. His expertise in pharmaceutical chemistry has led to advancements in drug development and therapeutic applications.

Collaborations

Benz has collaborated with notable professionals in his field, including Harold C. Kluender and Brian R. Dixon. These partnerships have contributed to the success of his innovative projects.

Conclusion

Guenter Hans Benz is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]